SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-013933
Filing Date
2017-07-25
Accepted
2017-07-25 16:05:23
Documents
1
Period of Report
2017-07-25
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K_ CASH BALANCE 2017_JUN 30 reta-8k_20170726.htm 8-K 26290
  Complete submission text file 0001564590-17-013933.txt   27341
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 17980483
SIC: 2834 Pharmaceutical Preparations